Bionano Genomics
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $6,073 | $7,771 | $8,769 | $10,721 |
Gross Profit | -8,178 | 2,585 | 2,824 | 2,438 |
EBITDA | -43,901 | -12,713 | -28,260 | -35,433 |
EBIT | -15,752 | -31,318 | -39,029 | |
Net Income | -44,246 | -16,224 | -31,422 | -43,891 |
Net Change In Cash | 6,073 | 7,771 | 8,769 | 10,721 |
Free Cash Flow | -13,309 | -21,055 | -28,157 | -35,045 |
Cash | 8,794 | 21,433 | 15,759 | 53,065 |
Basic Shares | 85,870 | 67,583 | 52,739 | 45,752 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $36,116 | $27,802 | $17,981 | $8,502 |
Gross Profit | 9,566 | 5,945 | 3,874 | 2,772 |
EBITDA | -213,604 | -120,315 | -73,855 | -37,071 |
EBIT | -227,312 | -130,414 | -77,826 | -38,551 |
Net Income | -232,493 | -132,596 | -72,435 | -41,135 |
Net Change In Cash | 36,116 | 27,802 | 17,981 | 8,502 |
Cost of Revenue | -19,042 | -13,878 | 21,137 | |
Free Cash Flow | -126,872 | -128,118 | -73,387 | -38,314 |
Cash | 17,948 | 5,091 | 24,571 | 38,448 |
Basic Shares | 34,150 | 28,921 | 27,678 | 10,425 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.26 |
2024-06-30 | -$0.22 |
2024-03-31 | -$0.51 |
2023-12-31 | -$0.95 |
